ES2176363T3 - PEPTIDES OF HIV GAG PROTEIN, ITS PREPARATION AND ITS USE. - Google Patents
PEPTIDES OF HIV GAG PROTEIN, ITS PREPARATION AND ITS USE.Info
- Publication number
- ES2176363T3 ES2176363T3 ES96100385T ES96100385T ES2176363T3 ES 2176363 T3 ES2176363 T3 ES 2176363T3 ES 96100385 T ES96100385 T ES 96100385T ES 96100385 T ES96100385 T ES 96100385T ES 2176363 T3 ES2176363 T3 ES 2176363T3
- Authority
- ES
- Spain
- Prior art keywords
- peptides
- preparation
- gag protein
- hiv gag
- hiv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 101710177291 Gag polyprotein Proteins 0.000 title abstract 2
- 101710125418 Major capsid protein Proteins 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
- C07K14/155—Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
LA INVENCION TRATA DE PEPTIDOS SELECCIONADOS DE LA PROTEINA GAG DEL HIV Y DERIVADOS, QUE TIENEN LA SECUENCIA PEPTIDICA AATLEEMMTA Y NO TIENEN MAS DE 50 AMINOACIDOS.THE INVENTION IS ABOUT SELECTED PEPTIDES OF THE GAG PROTEIN OF HIV AND DERIVATIVES, WHICH HAVE THE PEPTIDIC SEQUENCE AATLEEMMTA AND HAVE NO MORE THAN 50 AMINO ACIDS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4039925A DE4039925A1 (en) | 1990-12-14 | 1990-12-14 | SELECTED PEPTIDES OF THE GROUP-SPECIFIC ANTIGEN (GAG) OF HUMANEM IMMUNE DEFICIENCY VIRUS (HIV), THEIR PRODUCTION AND USE |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2176363T3 true ES2176363T3 (en) | 2002-12-01 |
Family
ID=6420301
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91121362T Expired - Lifetime ES2095899T3 (en) | 1990-12-14 | 1991-12-12 | HIV GAG PROTEIN PEPTIDES, THEIR PREPARATION AND USE. |
ES96100385T Expired - Lifetime ES2176363T3 (en) | 1990-12-14 | 1991-12-12 | PEPTIDES OF HIV GAG PROTEIN, ITS PREPARATION AND ITS USE. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91121362T Expired - Lifetime ES2095899T3 (en) | 1990-12-14 | 1991-12-12 | HIV GAG PROTEIN PEPTIDES, THEIR PREPARATION AND USE. |
Country Status (12)
Country | Link |
---|---|
US (1) | US5612453A (en) |
EP (2) | EP0490383B1 (en) |
JP (2) | JP3369585B2 (en) |
KR (1) | KR920012114A (en) |
AT (2) | ATE216706T1 (en) |
AU (1) | AU661464B2 (en) |
CA (1) | CA2057612C (en) |
DE (3) | DE4039925A1 (en) |
DK (2) | DK0732339T3 (en) |
ES (2) | ES2095899T3 (en) |
IE (1) | IE914353A1 (en) |
PT (1) | PT99791B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA903492B (en) * | 1989-05-15 | 1991-02-27 | Akzo Nv | T-lymphotropic retrovirus monoclonal antibodies |
US6426412B1 (en) * | 1995-12-20 | 2002-07-30 | Subsidiary No. 3, Inc. | Nucleic acids encoding human immunodeficiency virus type 1 genetic suppressor elements |
GB9703802D0 (en) * | 1997-02-24 | 1997-04-16 | Kingsman Susan M | Anti-hiv peptides and proteins |
NO314588B1 (en) | 2000-09-04 | 2003-04-14 | Bionor Immuno As | HIV peptides, antigens, vaccine composition, immunoassay test kits and a method for detecting antibodies induced by HIV |
US6818392B2 (en) | 2000-12-06 | 2004-11-16 | Abbott Laboratories | Monoclonal antibodies to human immunodeficiency virus and uses thereof |
EP1855112A1 (en) * | 2006-05-10 | 2007-11-14 | Inserm | Method for the in vitro screening of compounds inhibiting production of infectious HIV-1 virions |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE54757T1 (en) * | 1985-02-05 | 1990-08-15 | Us Commerce | PROCEDURE FOR DETECTING HTLV-III NEUTRALIZING ANTIBODIES IN SERA. |
KR910002374B1 (en) * | 1985-04-29 | 1991-04-20 | 제네틱 시스템즈 코포레이션 | Synthetic antigens for the detection of aids-relate disease |
US4629783A (en) * | 1985-04-29 | 1986-12-16 | Genetic Systems Corporation | Synthetic antigen for the detection of AIDS-related disease |
NO881151L (en) * | 1987-03-27 | 1988-09-28 | Syntello Ab | SYNTHETIC HIV-1 ANTIGEN. |
CA1339363C (en) * | 1987-05-01 | 1997-08-26 | Alan Ray Flesher | Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use |
EP0356007A3 (en) * | 1988-07-22 | 1991-07-03 | Medical Research Council | Antigenic determinants |
FR2640877A1 (en) * | 1988-12-06 | 1990-06-29 | Centre Nat Rech Scient | |
JP2994031B2 (en) * | 1988-12-20 | 1999-12-27 | クラリティ テクノロジーズ インコーポレイテッド | Method for determining the presence or amount of HIV-1 or HIV-2 antibody, immunospecific reagent, synthetic peptide, diagnostic kit, method for preparing HIV-1 or HIV-2 antibody, immunogen and antibody |
GB8910145D0 (en) * | 1989-05-03 | 1989-06-21 | Connaught Lab | Synthetic peptides for an hiv-1 vaccine |
NZ235538A (en) * | 1989-10-12 | 1992-06-25 | Viral Technologies Inc | Peptides immunoreactive with antibodies to hiv p17; carrier-bound peptides, vaccines, immunoassay and a method for forming antibody enriched sera |
CA2072351A1 (en) * | 1990-01-05 | 1991-07-06 | Andrew J. Mcmichael | Hiv-1 core protein fragments |
SE468168B (en) * | 1990-02-20 | 1992-11-16 | Replico Medical Ab | HIV-1, P24 PEPTIDES, DIAGNOSTIC ANTIGENS AND PROCEDURES FOR DIFFERENTIAL DIAGNOSTICS OF PRELIMINARY HIV-1 POSITIVE SERUM TESTS |
-
1990
- 1990-12-14 DE DE4039925A patent/DE4039925A1/en not_active Withdrawn
-
1991
- 1991-12-12 DE DE59109235T patent/DE59109235D1/en not_active Expired - Lifetime
- 1991-12-12 EP EP91121362A patent/EP0490383B1/en not_active Expired - Lifetime
- 1991-12-12 ES ES91121362T patent/ES2095899T3/en not_active Expired - Lifetime
- 1991-12-12 DK DK96100385T patent/DK0732339T3/en active
- 1991-12-12 ES ES96100385T patent/ES2176363T3/en not_active Expired - Lifetime
- 1991-12-12 DE DE59108261T patent/DE59108261D1/en not_active Expired - Lifetime
- 1991-12-12 AT AT96100385T patent/ATE216706T1/en not_active IP Right Cessation
- 1991-12-12 EP EP96100385A patent/EP0732339B1/en not_active Expired - Lifetime
- 1991-12-12 AT AT91121362T patent/ATE143974T1/en not_active IP Right Cessation
- 1991-12-12 DK DK91121362.7T patent/DK0490383T3/en active
- 1991-12-13 PT PT99791A patent/PT99791B/en not_active IP Right Cessation
- 1991-12-13 JP JP35235391A patent/JP3369585B2/en not_active Expired - Lifetime
- 1991-12-13 KR KR1019910022867A patent/KR920012114A/en not_active Application Discontinuation
- 1991-12-13 AU AU89766/91A patent/AU661464B2/en not_active Ceased
- 1991-12-13 IE IE435391A patent/IE914353A1/en unknown
- 1991-12-13 CA CA002057612A patent/CA2057612C/en not_active Expired - Lifetime
-
1994
- 1994-12-13 US US08/356,798 patent/US5612453A/en not_active Expired - Lifetime
-
2002
- 2002-09-13 JP JP2002269239A patent/JP2003176299A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
ES2095899T3 (en) | 1997-03-01 |
EP0490383A2 (en) | 1992-06-17 |
ATE216706T1 (en) | 2002-05-15 |
DK0732339T3 (en) | 2002-08-19 |
CA2057612C (en) | 2002-02-05 |
JP3369585B2 (en) | 2003-01-20 |
AU8976691A (en) | 1992-06-18 |
KR920012114A (en) | 1992-07-25 |
AU661464B2 (en) | 1995-07-27 |
EP0490383A3 (en) | 1993-06-30 |
DK0490383T3 (en) | 1997-02-17 |
DE59108261D1 (en) | 1996-11-14 |
DE59109235D1 (en) | 2002-05-29 |
PT99791B (en) | 1999-05-31 |
JPH06107697A (en) | 1994-04-19 |
IE914353A1 (en) | 1992-06-17 |
CA2057612A1 (en) | 1992-06-15 |
US5612453A (en) | 1997-03-18 |
EP0732339B1 (en) | 2002-04-24 |
JP2003176299A (en) | 2003-06-24 |
DE4039925A1 (en) | 1992-06-17 |
EP0490383B1 (en) | 1996-10-09 |
ATE143974T1 (en) | 1996-10-15 |
EP0732339A1 (en) | 1996-09-18 |
PT99791A (en) | 1992-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2009002139A1 (en) | Synthetic peptide comprising the sequence sec id no: 6 and sec id no: 7 of the hiv virus gp41 protein with antiretroviral activity. | |
ES2123134T3 (en) | BIOLOGICALLY ACTIVE PEPTIDES OF FUNCTIONAL DOMAINS OF PERMEABILITY-INCREASING BACTERICIDE PROTEIN AND USES THEREOF. | |
DE59101397D1 (en) | O-GLYCOSYLATED IFN ALPHA. | |
ES2054842T3 (en) | ANALOGUE OF FACTOR VIII, PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITION THAT CONTAINS IT. | |
ATA144090A (en) | FORMULATIONS WITH SLOW RELEASE OF WATER-SOLUBLE PEPTIDES | |
BR9605153B1 (en) | combination vaccine and vaccination kit. | |
TR199501669A1 (en) | Aerosol formulations of peptide and proteins. | |
CY1110927T1 (en) | AMINO-CUTTING BRANCHED RANTES AS COMPETENT TO CHEMICALS | |
BR9006934A (en) | STABILIZED AQUEOUS FORMULATIONS OF SMALL PEPTIDES | |
NO912825L (en) | PROCEDURE FOR THE PREPARATION OF COCONJUGATE VACCINES INCLUDING IM MUNOGENT PROTEIN, HIV RELATED PEPTIDES AND ANIONIC GROUPS. | |
MX9200709A (en) | IMPROVED ACTIVATION OF RECOMBINED PROTEINS. IMPROVED ACTIVATION OF RECOMBINED PROTEINS. | |
DE69322872D1 (en) | VACCINE AGAINST THE CAT'S IMMUNODEFICIENCY VIRUS (KIV) | |
ES2180948T3 (en) | PEPTIDE THAT COMES FROM A SOLUBLE FORM OF ACETILCOLINESTERASE, ACTIVE AS A CHANNEL MODULATOR. | |
DK0470980T3 (en) | Synthetic peptides for an HIV-1 vaccine | |
ES2176363T3 (en) | PEPTIDES OF HIV GAG PROTEIN, ITS PREPARATION AND ITS USE. | |
HUP9801572A2 (en) | Chlamydia vaccines | |
IT1249684B (en) | HEPATITIS VIRUS PROTEIN ENV EPITOPES | |
DE69230106D1 (en) | PEPTIDE-ANTIGENE COMPOSED OF MULTI-DETERMINANTS THAT STIMULATE THE T-HELPER'S LYMPHOCYTE RESPONSE TO HIV IN A WIDE RANGE OF AFFECTED PEOPLE | |
DE69122103D1 (en) | ANTI-GUARD PEPTIDES | |
ES2071038T3 (en) | PEPTIDES ASSOCIATED WITH HIV. | |
DE69434151D1 (en) | THERAPEUTIC INGREDIENTS | |
NO891926L (en) | PROCEDURE FOR THE PREPARATION OF STABLE PROTEIN OR PEPTIDE PREPARATIONS. | |
DE69012989D1 (en) | PEPTIDES OF RETINBLASTOMA GENE PRODUCTS AND ANTIBODIES AGAINST. | |
AP9801399A0 (en) | Zona pellucida proteins for contraception. | |
ATE174963T1 (en) | CLONING AND EXPRESSION OF A RHOPTRY-ASSOCIATED PROTEIN FROM P. FALCIPARUM |